the aid library

LIST OPTIONS

Filter

3104

Sort by:

Direction:

Download (39)

View PDF (94)

WHO consolidated guidelines on tuberculosis Module 1: prevention - tuberculosis preventive treatment, second edition

World Health Organisation (WHO) (2024) C_WHO

About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im... more

Download (125)

View PDF (138)

Chemotherapy of second-stage Human African trypanosomiasis

Lutje, V.; Seixas, J.; Kennedy, A. Chochrane Library (2013) C2

Human African trypanosomiasis (HAT), or sleeping sickness, is a painful and protracted disease transmitted through the bite of infected tsetse flies and it is found in rural parts of sub-Saharan Africa. Sleeping sickness has two clinical phases but this review focuses only on treatment of the second... more

Download (97)

View PDF (1346)

Patient Safety

World Health Organization WHO (2019) C_WHO

Patient Safety is a health care discipline that emerged with the evolving complexity in health care systems and the resulting rise of patient harm in health care facilities. It aims to prevent and reduce risks, errors and harm that occur to patients during provision of health care. A cornerstone of ... more

Download (184)

View PDF (199)

Global leishmaniasis surveillance: 2021, assessing the impact of the COVID-19 pandemic

Ruiz-Postigo, J.A.; et al. World Health Organization WHO (2022) C_WHO

Surveillance mondiale de la leishmaniose: 2021, évaluation de l’impact de la pandémie de COVID-19 The aims of this report are to update the results of the GHO leishmaniasis indicators reported by Member States to WHO up to 2021, to describe specific indicators of gender and age distribution, re... more

Download (103)

View PDF (999)

Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended

H. Adler, Gould, S.; Hine, P.; et al. The Lancet (2022) CC

Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated eff... more

Download (232)

View PDF (289)

Review on palliative care with focus on 18 high tuberculosis priority countries

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Tuberculosis (‎TB)‎ is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h... more

Download (88)

View PDF (141)

Interim guidance on selecting, commissioning and using freeze-preventative vaccine carriers

World Health Organization WHO (2021) C_WHO

Interim Guidance, published 11 January 2021. The cold chain is necessary to prevent damage to vaccines caused by heat exposure. However, improper use of cold chain equipment may cause damage to freeze-sensitive vaccines (i.e. those vaccines containing alum adjuvant or oil-emulsion adjuvant). Studie... more

Download (1275)

View PDF (3334)

Global guidelines on the prevention of surgical site infection. 2nd edition
recommended

World Health Organization WHO (2018) C_WHO

These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences. The 2018 edition of the guidelines includes the re... more

Download (26)

View PDF (23)

Global Initiative for Chronic Obstructive Lung Disease - Report 2023

Global Initiative for Chronic Obstructive Lung Disease – GOLD (2023) CC2

The aim of the GOLD Report is to provide a non-biased review of the current evidence for the assessment, diagnosis and treatment of people with COPD. One of the strengths of GOLD reports is the treatment objectives. These have stood the test of time, and are organized into two groups: objectives tha... more

Download (139)

View PDF (177)

The dual threat of extreme weather and the COVID-19 crisis: Anticipating the impacts on food availability

Food and Agriculture Organization of the United Nations FAO (2020) C1

The COVID-19 pandemic is having a profound negative effect on the global economy and is occurring in the context of a rapidly changing climate. This year is expected to be the second hottest in recorded history. Weather forecasts for 2020 indicate a high probability that extreme weather will adverse... more

Download (37)

View PDF (42)

South African cardiovascular risk stratification guideline for non-cardiac surgery

Alphonsus, C.; Naidoo, N.; Motshabi, P. et al. South African Medical Journal (2021) CC

The South African (SA) guidelines for cardiac patients for non-cardiac surgery were developed to address the need for cardiac risk assessment and risk stratification for elective non-cardiac surgical patients in SA, and more broadly in Africa. The guidelines were developed by updating the Canadian ...Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Non-cardiac Surgery, with a search of literature from African countries and recent publications. The updated proposed guidelines were then evaluated in a Delphi consensus process by SA anaesthesia and vascular surgical experts. The recommendations in these guidelines are: 1. We suggest that elective non-cardiac surgical patients who are 45 years and older with either a history of coronary artery disease, congestive cardiac failure, stroke or transient ischaemic attack, or vascular surgical patients 18 years or older with peripheral vascular disease require further preoperative risk stratification as their predicted 30-day major adverse cardiac event (MACE) risk exceeds 5% (conditional recommendation: moderate-quality evidence). 2. We do not recommend routine non-invasive testing for cardiovascular risk stratification prior to elective non-cardiac surgery in adults (strong recommendation: low-to-moderate-quality evidence). 3. We recommend that elective non-cardiac surgical patients who are 45 years and older with a history of coronary artery disease, or stroke or transient ischaemic attack, or congestive cardiac failure or vascular surgical patients 18 years or older with peripheral vascular disease should have preoperative natriuretic peptide (NP) screening (strong recommendation: high-quality evidence). 4. We recommend daily postoperative troponin measurements for 48 - 72 hours for non-cardiac surgical patients who are 45 years and older with a history of coronary artery disease, or stroke or transient ischaemic attack, or congestive cardiac failure or vascular surgical patients 18 years or older with peripheral vascular disease, i.e. (i) a baseline risk >5% for MACE 30 days after elective surgery (if no preoperative NP screening), or (ii) an elevated B-type natriuretic peptide (BNP)/N-terminal-prohormone B-type natriuretic peptide (NT-proBNP) measurement before elective surgery (defined as BNP >99 pg/mL or a NT-proBNP >300 pg/mL) (conditional recommendation: moderate-quality evidence). Additional recommendations are given for the management of myocardial injury after non-cardiac surgery (MINS) and medications for comorbidities. more

Download (415)

View PDF (1061)

Uganda: THE NATIONAL DRUG POLICY AND AUTHORITY (PHARMACOVIGILANCE) REGULATIONS, 2014

The Government of Uganda The Uganda Gazette (2014) C2

Download (792)

View PDF (1704)

Surveillance des manifestations indésirables consécutives à la vaccination contre la fièvre jaune

Organisation Mondiale de la Santé OMS (2010) C_WHO

GUIDE OPÉRATIONNEL à l'usage du personnel de niveau central, intermédiaire et périphérique

Download (157)

View PDF (238)

Chagas Disease: Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV Clinical Info HIV (2018) CC

Epidemiology Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or... more

Download (629)

View PDF (767)

Zimbabwe National Pharmacovigilance Policy Handbook, 2nd ed.

Medicines Control Authority of Zimbabwe (MCAZ) | Ministry of Health and Child Care (2016) C2

The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.

Download (456)

View PDF (951)

Nigeria: GOOD PHARMACOVIGILANCE PRACTICE GUIDELINES

National Agency for Food and Drugs Administration and Control (NAFDAC) (2016) C2

Download (1056)

View PDF (802)

Tanzania: National Guidelines for Monitoring Medicines Safety

Tanzania Food & Drugs Authority (TFDA) (2010) C2

Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition

Download (1256)

View PDF (3121)

Indicator-Based Pharmacovigilance Assessment Tool: Manual for Conducting Assessments in Developing Countries.
recommended

Strengthening Pharmaceutical Systems (SPS) Program (2009) C1

This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.

Download (231)

View PDF (205)

Guideline for Adverse Drug Reactions Reporting for Healthcare Professionals

SAHPRA (2020) CC

Communication to Healthcare Professionals Mar-2020 This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o... more

Download (99)

View PDF (353)

Africa CDC Event-based Surveillance Resources

Africa Center for Disease Control and Prevention (2023) CC

The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing event-based surveillance (EBS) using a multisectoral, One Health approach. To ... more

Clinical features and management of human monkeypox: a retrospective observational study in the UK recommended

Global guidelines on the prevention of surgical site infection. 2nd edition recommended

Indicator-Based Pharmacovigilance Assessment Tool: Manual for Conducting Assessments in Developing Countries. recommended

Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended

Global guidelines on the prevention of surgical site infection. 2nd edition
recommended

Indicator-Based Pharmacovigilance Assessment Tool: Manual for Conducting Assessments in Developing Countries.
recommended